Correction to: RIC in COVID-19-a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19
Cardiovasc Drugs Ther
.
2022 Oct;36(5):931.
doi: 10.1007/s10557-021-07223-w.
Authors
Sean M Davidson
1
,
Kishal Lukhna
2
,
Diana A Gorog
3
,
Alan D Salama
4
,
Alejandro Rosell Castillo
5
,
Sara Giesz
1
,
Pelin Golforoush
1
,
Siavash Beikoghli Kalkhoran
1
,
Sandrine Lecour
6
,
Aqeela Imamdin
6
,
Helison R P do Carmo
5
,
Ticiane Gonçalez Bovi
5
,
Mauricio W Perroud Jr
5
,
Mpiko Ntsekhe
2
,
Andrei C Sposito
5
,
Derek M Yellon
7
Affiliations
1
The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK.
2
Division of Cardiology, Groote Schuur Hospital and Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
3
Postgraduate Medicine, University of Hertfordshire, UK & East and North Hertfordshire NHS Trust, Stevenage, Hertfordshire, UK.
4
Department of Renal Medicine, Royal Free Hospital, London, UK.
5
Atherosclerosis and Vascular Biology Laboratory, State University of Campinas, Campinas, Brazil.
6
The Hatter Institute for Cardiovascular Research, University of Cape Town, Cape Town, South Africa.
7
The Hatter Cardiovascular Institute, University College, London, 67 Chenies Mews, London, WC1E 6HX, UK.
[email protected]
.
PMID:
34232434
PMCID:
PMC8261032
DOI:
10.1007/s10557-021-07223-w
No abstract available
Publication types
Published Erratum